A particular subset of the population, namely, those who are treated by TNF-α inhibitors, might be at a disadvantage despite a paucity of reports on the prevalence and manifestations of Q fever in persons treated by anti-TNF-α medicines. The gene discussed is TNF; the disease is Q fever.